share_log

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga ·  Jan 15 23:05

Gainers

  • Helius Medical Tech (NASDAQ:HSDT) shares moved upwards by 32.6% to $0.92 during Wednesday's pre-market session. The company's market cap stands at $3.4 million.
  • Climb Bio (NASDAQ:CLYM) stock increased by 19.25% to $2.23. The market value of their outstanding shares is at $150.0 million.
  • Exicure (NASDAQ:XCUR) shares moved upwards by 15.42% to $9.95. The market value of their outstanding shares is at $30.2 million.
  • Rapid Micro Biosystems (NASDAQ:RPID) stock increased by 14.67% to $1.25. The company's market cap stands at $53.7 million.
  • Generation Bio (NASDAQ:GBIO) shares increased by 11.36% to $0.98. The company's market cap stands at $65.4 million.
  • Context Therapeutics (NASDAQ:CNTX) shares moved upwards by 11.09% to $1.1. The market value of their outstanding shares is at $82.4 million.

Losers

  • Anitra (AMEX:AZTR) stock fell 29.1% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.2 million.
  • GlucoTrack (NASDAQ:GCTK) stock fell 23.2% to $0.09. The company's market cap stands at $1.5 million.
  • Jin Medical International (NASDAQ:ZJYL) shares fell 20.2% to $0.83. The market value of their outstanding shares is at $129.9 million.
  • Theriva Biologics (AMEX:TOVX) shares fell 15.19% to $1.62. The company's market cap stands at $4.5 million.
  • Phio Pharma (NASDAQ:PHIO) stock declined by 14.53% to $3.06. The company's market cap stands at $5.3 million.
  • Ardent Health Partners (NYSE:ARDT) stock declined by 14.52% to $12.01. The market value of their outstanding shares is at $1.7 billion.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment